BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38804179)

  • 21. Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.
    Fares W; Ghedira K; Gdoura M; Chouikha A; Haddad-Boubaker S; Khedhiri M; Ayouni K; Lamari A; Touzi H; Hammemi W; Medeb Z; Sadraoui A; Hogga N; Ben Alaya N; Triki H
    Microbiol Spectr; 2021 Dec; 9(3):e0063921. PubMed ID: 34756072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
    Díez-Fuertes F; Iglesias-Caballero M; García-Pérez J; Monzón S; Jiménez P; Varona S; Cuesta I; Zaballos Á; Jiménez M; Checa L; Pozo F; Pérez-Olmeda M; Thomson MM; Alcamí J; Casas I
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33127745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large-scale sequencing of SARS-CoV-2 genomes from one region allows detailed epidemiology and enables local outbreak management.
    Page AJ; Mather AE; Le-Viet T; Meader EJ; Alikhan NF; Kay GL; de Oliveira Martins L; Aydin A; Baker DJ; Trotter AJ; Rudder S; Tedim AP; Kolyva A; Stanley R; Yasir M; Diaz M; Potter W; Stuart C; Meadows L; Bell A; Gutierrez AV; Thomson NM; Adriaenssens EM; Swingler T; Gilroy RAJ; Griffith L; Sethi DK; Aggarwal D; Brown CS; Davidson RK; Kingsley RA; Bedford L; Coupland LJ; Charles IG; Elumogo N; Wain J; Prakash R; Webber MA; Smith SJL; Chand M; Dervisevic S; O'Grady J; The Covid-Genomics Uk Cog-Uk Consortium
    Microb Genom; 2021 Jun; 7(6):. PubMed ID: 34184982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ongoing global and regional adaptive evolution of SARS-CoV-2.
    Rochman ND; Wolf YI; Faure G; Mutz P; Zhang F; Koonin EV
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34292871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between prognostic factors and the outcomes of patients infected with SARS-CoV-2 harboring multiple spike protein mutations.
    Gunadi ; Hakim MS; Wibawa H; Marcellus ; Trisnawati I; Supriyati E; Afiahayati ; Khair RE; Iskandar K; Siswanto ; Irene ; Anggorowati N; Daniwijaya EW; Nugrahaningsih DAA; Puspadewi Y; Simanjaya S; Puspitarani DA; Hanifin HF; Setiawan AA; Tania I; Amalia CS; Artayasa IPA; Rachman H; Mulyawan H; Ananda NR; Arguni E; Nuryastuti T; Wibawa T
    Sci Rep; 2021 Nov; 11(1):21352. PubMed ID: 34725366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants.
    Weigang S; Fuchs J; Zimmer G; Schnepf D; Kern L; Beer J; Luxenburger H; Ankerhold J; Falcone V; Kemming J; Hofmann M; Thimme R; Neumann-Haefelin C; Ulferts S; Grosse R; Hornuss D; Tanriver Y; Rieg S; Wagner D; Huzly D; Schwemmle M; Panning M; Kochs G
    Nat Commun; 2021 Nov; 12(1):6405. PubMed ID: 34737266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
    Li X; Zhang L; Chen S; Ji W; Li C; Ren L
    Infect Genet Evol; 2021 Sep; 93():104971. PubMed ID: 34146731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SARS-CoV-2 Genomic Variation in Space and Time in Hospitalized Patients in Philadelphia.
    Everett J; Hokama P; Roche AM; Reddy S; Hwang Y; Kessler L; Glascock A; Li Y; Whelan JN; Weiss SR; Sherrill-Mix S; McCormick K; Whiteside SA; Graham-Wooten J; Khatib LA; Fitzgerald AS; Collman RG; Bushman F
    mBio; 2021 Jan; 12(1):. PubMed ID: 33468702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 Omicron Variant Genomic and Phylogenetic Analysis in Iraqi Kurdistan Region.
    Majed SO; Mustafa SA; Jalal PJ; Fatah MH; Miasko M; Jawhar Z; Karim AY
    Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of intrinsic and effective fitness changes caused by temporarily fixed mutations in the SARS-CoV-2 spike E484 epitope and identification of an epistatic precondition for the evolution of E484A in variant Omicron.
    Schröder S; Richter A; Veith T; Emanuel J; Gudermann L; Friedmann K; Jeworowski LM; Mühlemann B; Jones TC; Müller MA; Corman VM; Drosten C
    Virol J; 2023 Nov; 20(1):257. PubMed ID: 37940989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2.
    Laiton-Donato K; Franco-Muñoz C; Álvarez-Díaz DA; Ruiz-Moreno HA; Usme-Ciro JA; Prada DA; Reales-González J; Corchuelo S; Herrera-Sepúlveda MT; Naizaque J; Santamaría G; Rivera J; Rojas P; Ortiz JH; Cardona A; Malo D; Prieto-Alvarado F; Gómez FR; Wiesner M; Martínez MLO; Mercado-Reyes M
    Infect Genet Evol; 2021 Nov; 95():105038. PubMed ID: 34403832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico.
    Rodríguez-Maldonado AP; Vázquez-Pérez JA; Cedro-Tanda A; Taboada B; Boukadida C; Wong-Arámbula C; Nuñez-García TE; Cruz-Ortiz N; Barrera-Badillo G; Hernández-Rivas L; López-Martínez I; Mendoza-Vargas A; Reyes-Grajeda JP; Alcaraz N; Peñaloza-Figueroa F; Gonzalez-Barrera D; Rangel-DeLeon D; Herrera-Montalvo LA; Mejía-Nepomuceno F; Hernández-Terán A; Mújica-Sánchez M; Becerril-Vargas E; Martínez-Orozco JA; Pérez-Padilla R; Salas-Hernández J; Sanchez-Flores A; Isa P; Matías-Florentino M; Ávila-Ríos S; Muñoz-Medina JE; Grajales-Muñiz C; Salas-Lais AG; Santos Coy-Arechavaleta A; Hidalgo-Miranda A; Arias CF; Ramírez-González JE
    Arch Virol; 2021 Nov; 166(11):3173-3177. PubMed ID: 34448936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia.
    Armero A; Berthet N; Avarre JC
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33477885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence and expansion of highly infectious spike protein D614G mutant SARS-CoV-2 in central India.
    Sharma S; Dash PK; Sharma SK; Srivastava A; Kumar JS; Karothia BS; Chelvam KT; Singh S; Gupta A; Yadav RG; Yadav R; Greeshma TS; Kushwaha PK; Kumar RB; Nagar DP; Nandan M; Kumar S; Thavaselvam D; Dubey DK
    Sci Rep; 2021 Sep; 11(1):18126. PubMed ID: 34518554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
    Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G
    Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 evolution during treatment of chronic infection.
    Kemp SA; Collier DA; Datir RP; Ferreira IATM; Gayed S; Jahun A; Hosmillo M; Rees-Spear C; Mlcochova P; Lumb IU; Roberts DJ; Chandra A; Temperton N; ; ; Sharrocks K; Blane E; Modis Y; Leigh KE; Briggs JAG; van Gils MJ; Smith KGC; Bradley JR; Smith C; Doffinger R; Ceron-Gutierrez L; Barcenas-Morales G; Pollock DD; Goldstein RA; Smielewska A; Skittrall JP; Gouliouris T; Goodfellow IG; Gkrania-Klotsas E; Illingworth CJR; McCoy LE; Gupta RK
    Nature; 2021 Apr; 592(7853):277-282. PubMed ID: 33545711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage.
    Colson P; Levasseur A; Delerce J; Pinault L; Dudouet P; Devaux C; Fournier PE; La Scola B; Lagier JC; Raoult D
    Clin Microbiol Infect; 2021 Sep; 27(9):1352.e1-1352.e5. PubMed ID: 33991677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.
    Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
    mBio; 2021 Aug; 12(4):e0114021. PubMed ID: 34465019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.